Collaborative Strategies: Urologists and Oncologists Enhancing Outcomes for High-Risk NMIBC

Key Takeaways

• Urologists need oncologists to provide systemic therapy insights and manage immune-related adverse events in combination therapy.
• Oncologists rely on urologists for expertise in local disease management and patient selection for combination therapy.
• Effective communication and shared decision-making are vital for tailoring treatment plans and monitoring patient progress.
• Collaboration enhances patient care and improves clinical outcomes in high-risk non–muscle-invasive bladder cancer.